4543 — Terumo Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapHigh Flyer

Annual cashflow statement for Terumo, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Tanshin
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	106,466	97,060	114,501	116,137	140,829
Depreciation
Non-Cash Items	1,630	3,261	3,412	3,592	2,600
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-42,975	-32,768	-35,328	-72,431	-73,845
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	117,479	121,485	141,467	117,536	146,329
Capital Expenditures	-83,484	-83,124	-74,105	-72,173	-78,774
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-1,230	-2,193	-4,349	13,052	-2,698
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	-84,714	-85,317	-78,454	-59,121	-81,472
Financing Cash Flow Items	158	-1	-1	-1	-1
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	14,010	-7,436	-70,879	-86,559	-62,079
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	43,916	33,871	4,481	-17,929	17,560